Autosomal-dominant GTPCH1-deficient DRD: clinical characteristics and long-term outcome of 34 patients

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Journal of Neurology Neurosurgery & Psychiatry

• Publication date

  2009-03-29

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/jnnp.2008.155861PMID 19332422
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Adult‐onset dystonia: Atypical manifestation of Segawa disease

  2007cited by this paper
• Estrogen-triggered activation of GTP cyclohydrolase 1 gene expression: role of estrogen receptor subtypes and interaction with cyclic AMP.

  2006cited by this paper
• A case of late-onset Segawa syndrome (autosomal dominant dopa-responsive dystonia) with a novel mutation of the GTP-cyclohydrase I (GCH1) gene.

  2006cited by this paper
• Expanded motor and psychiatric phenotype in autosomal dominant Segawa syndrome due to GTP cyclohydrolase deficiency

  2006cited by this paper
• Dopa‐responsive dystonia and early‐onset Parkinson's disease in a patient with GTP cyclohydrolase I deficiency?

  2006cited by this paper
• Broadening the phenotype of childhood-onset dopa-responsive dystonia.

  2006cited by this paper
• High mutation rate in dopa-responsive dystonia: Detection with comprehensive GCHI screening

  2005cited by this paper
• Diagnostic evaluation of patients with a brain mass as the presenting manifestation of cancer

  2005cited by this paper
• BIOMDB : Database of Mutations Causing Tetrahydrobiopterin Deficiencies

  2005cited by this paper
• Expanded motor and psychiatric phenotype in autosomal dominant Segawa syndrome due to GTP cyclohydrolase deficiency

  2005cited by this paper
• A point mutation in the tyrosine hydroxylase gene associated with Segawa's syndrome

  2004cited by this paper
• Update on dopa-responsive dystonia: locus heterogeneity and biochemical features.

  2004cited by this paper
• Genetics and biochemistry of dopa-responsive dystonia: significance of striatal tyrosine hydroxylase protein loss.

  2003cited by this paper
• Autosomal dominant guanosine triphosphate cyclohydrolase I deficiency (Segawa disease)

  2003cited by this paper
• Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology. A report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health.

  2003cited by this paper
• Autosomal dominant GTP-CH deficiency presenting as a dopa-responsive myoclonus-dystonia syndrome.

  2002cited by this paper
• Revised prevalence estimates of mental disorders in the United States: using a clinical significance criterion to reconcile 2 surveys' estimates.

  2002cited by this paper
• Atypical presentation of dopa-responsive dystonia

  2001cited by this paper
• A splice mutation in the GTP cyclohydrolase I gene causes dopa-responsive dystonia by exon skipping

  2001cited by this paper
• Levodopa-responsive dystonia. GTP cyclohydrolase I or parkin mutations?

  2000cited by this paper
• Hereditary progressive dystonia with marked diurnal fluctuation.

  2000cited by this paper
• Dopa-responsive dystonia: Mutation analysis of GCH1 and analysis of therapeutic doses of l-dopa

  2000cited by this paper
• GTP Cyclohydrolase I Gene Expression in the Brains of Male and Female hph‐1 Mice

  1999cited by this paper
• GTP cyclohydrolase deficiency; intrafamilial variation in clinical phenotype, including levodopa responsiveness

  1999cited by this paper
• Dopa‐responsive dystonia: Recent advances and remaining issues to be addressed

  1999cited by this paper
• Dopa‐responsive dystonia: A clinical and molecular genetic study

  1998cited by this paper
• Dystonias responding to levodopa and failure in biopterin metabolism.

  1998cited by this paper
• Dopa responsive dystonia with Turner’s syndrome: clinical, genetic, and neuropsychological studies in a family with a new mutation in the GTP-cyclohydrolase I gene

  1998cited by this paper
• Dystonia with motor delay in compound heterozygotes for GTP‐cyclohydrolase I gene mutations

  1998cited by this paper
• Two previously unrecognized splicing mutations of GCH1 in Dopa-responsive dystonia: exon skipping and one base insertion

  1997cited by this paper
• Dopa-responsive dystonia in British patients: new mutations of the GTP-cyclohydrolase I gene and evidence for genetic heterogeneity.

  1996cited by this paper
• Characterization of Mouse and Human GTP Cyclohydrolase I Genes

  1995cited by this paper
• Hereditary progressive dystonia with marked diurnal fluctuation caused by mutations in the GTP cyclohydrolase I gene

  1994cited by this paper
• Dopa-responsive dystonia : clinical characteristics and definition

  1993cited by this paper
• Long‐term treatment response and fluorodopa positron emission tomographic scanning of parkinsonism in a family with dopa‐responsive dystonia

  1992cited by this paper
• Clinical and genetic analysis of progressive dystonia with diurnal variation.

  1991cited by this paper
• B. TYROSINE HYDROXYLASE

  1966cited by this paper
• TYROSINE HYDROXYLASE. THE INITIAL STEP IN NOREPINEPHRINE BIOSYNTHESIS.

  1964cited by this paper
• Studies on the mechanism of the enzymatic conversion of phenylalanine to tyrosine.

  1959cited by this paper

• A Novel Missense Variant in the GCH1 Gene Identified in Patients with Dopa-Responsive Dystonia

  2026cites this paper
• Genetics of upper limb tremor in clinical practice: a systematic literature review.

  2025cites this paper
• Pathogenic Variant in the 5’-Untranslated Region of GCH1 and Clinical Heterogeneity in a Chinese Family with Dopa-Responsive Dystonia

  2025cites this paper
• Spectrum of Inherited Childhood‐Onset Dystonia: Case Series of 19 Families With Genotype and Phenotype Characterization Highlighting the Treatable Causes

  2025influential citation
• Autosomal Recessive Guanosine Triphosphate Cyclohydrolase I Deficiency: Redefining the Phenotypic Spectrum and Outcomes

  2024cites this paper
• Chloroprocaine 3% for anesthesia during cesarean section in a patient with dopa-responsive dystonia: A case report

  2024cites this paper
• BDNF-Regulated Modulation of Striatal Circuits and Implications for Parkinson’s Disease and Dystonia

  2024cites this paper
• Dystonia and tremor: Do they have a shared biology?

  2023cites this paper
• The role of laboratory investigations in the classification of tremors

  2023cites this paper
• Crucial neuroprotective roles of the metabolite BH4 in dopaminergic neurons

  2023cites this paper
• Dystonia and Parkinson's disease: Do they have a shared biology?

  2023cites this paper
• Oromandibular Dystonia is a Prominent Feature in Patients with Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency

  2023cites this paper
• Démarche diagnostique générale devant un patient présentant des mouvements anormaux : importance des examens biologiques dans cette stratégie

  2023cites this paper
• Isolated and combined dystonias: Update.

  2023cites this paper
• Age- and sex-related oculomotor manifestation of dopamine deficiency in Segawa disease.

  2023cites this paper
• Phenotypes and Genotypes of Inherited Disorders of Biogenic Amine Neurotransmitter Metabolism

  2023cites this paper
• Heterozygous pathogenic variant in GCH1 associated with treatable severe spastic tetraplegia: Expert opinion.

  2023cites this paper
• Rare tremors and tremors occurring in other neurological disorders.

  2022cites this paper
• Early recognition of SGCE‐myoclonus–dystonia in children

  2022cites this paper
• Evidence That Substantia Nigra Pars Compacta Dopaminergic Neurons Are Selectively Vulnerable to Oxidative Stress Because They Are Highly Metabolically Active

  2022cites this paper
• Serotonergic system in vivo with [11C]DASB PET scans in GTP-cyclohydrolase deficient dopa-responsive dystonia patients

  2022cites this paper
• Clinical Manifestations and Molecular Backgrounds of Parkinson's Disease Regarding Genes Identified From Familial and Population Studies

  2022cites this paper
• Diagnostic approach in adult-onset neurometabolic diseases

  2022cites this paper
• Tics, tremors and other movement disorders in childhood.

  2021cites this paper
• Treatable Hyperkinetic Movement Disorders Not to Be Missed

  2021cites this paper
• Genetic landscape of Segawa disease in Spain. Long-term treatment outcomes.

  2021cites this paper
• Oromandibular Dystonia – A Systematic Review

  2021cites this paper
• Parkinsonism and tremor syndromes.

  2021cites this paper
• Recognizing Atypical Dopa-Responsive Dystonia and Its Mimics

  2021cites this paper
• Eye motor manifestations in children with neurometabolic disorders.

  2021cites this paper
• Second hit hypothesis in dystonia: Dysfunctional cross talk between neuroplasticity and environment?

  2021cites this paper
• Case Report: Guitarist’s cramp as the initial manifestation of dopa-responsive dystonia with a novel heterozygous GCH1 mutation

  2021cites this paper
• Inter and intra-generational phenotypic variability in a Portuguese family with DYT-GCH1.

  2021cites this paper
• Early-onset autosomal dominant GTP-cyclohydrolase I deficiency: Diagnostic delay and residual motor signs.

  2021cites this paper
• Dopa-responsive dystonia, DRD-plus and DRD look-alike: a pragmatic review

  2021cites this paper
• The role of reactive oxygen species in the pathogenic pathways of depression

  2020cites this paper
• Clinical and Genetic Heterogeneity in a Cohort of Chinese Children With Dopa-Responsive Dystonia

  2020cites this paper
• GCH-1 genetic variant may cause Parkinsonism by unmasking the subclinical nigral pathology

  2020cites this paper
• Differences in Drug Pharmacokinetics and Motor Fluctuation in DYT-GCH1

  2020influential citation
• Dopa-Responsive Dystonia: A Male Patient Inherited a Novel GCH1 Deletion from an Asymptomatic Mother

  2020cites this paper
• Series of Dopa Responsive Dystonia Masquerading as Other Diseases with Short Review

  2020cites this paper
• Movement Disorders and Inherited Metabolic Disorders

  2020cites this paper
• Drugs in the Treatment of Dystonia, Multisystem Atrophy, and Non-Parkinson Tremor

  2020cites this paper
• Consensus guideline for the diagnosis and treatment of tetrahydrobiopterin (BH4) deficiencies

  2020cites this paper
• Oral pharmacotherapy of dystonia

  2020cites this paper
• Tetrahydrobioterin (BH4) pathway: from metabolism to neuropsychiatry.

  2020cites this paper
• Isolated and combined genetic tremor syndromes: a critical appraisal based on the 2018 MDS criteria.

  2020cites this paper
• Clinical characteristics and diagnostic clues to Neurometabolic causes of dystonia.

  2020cites this paper
• Treatment of Dystonia: Medications, Neurotoxins, Neuromodulation, and Rehabilitation

  2020cites this paper
• Combined dystonias: clinical and genetic updates

  2020cites this paper
• Tetrahydrobioterin (BH4) Pathway: From Metabolism to Neuropsychiatry

  2020cites this paper
• Dopa-responsive dystonia

  2020cites this paper
• Disorders of manganese transport

  2019cites this paper
• GLUT1 Deficiency in a Patient Diagnosed as Cerebral Palsy: Is NGS a Valuable Tool to Be Considered in All Cases of CP to Detect Underlying Genetic Disorders?

  2019cites this paper
• Pure hypotonia in a four-year-old patient: An atypical presentation of Dopa-responsive dystonia.

  2019cites this paper
• Movement Disorders in Treatable Inborn Errors of Metabolism

  2019cites this paper
• Blepharospasm as a Manifestation of Peak of Dose Dyskinesia in Parkinson Disease

  2019cites this paper
• Treatment of Dopa-Responsive Dystonia

  2019cites this paper
• Juvenile parkinsonism: Differential diagnosis, genetics, and treatment.

  2019cites this paper
• Dopa-responsive dystonia

  2019cites this paper
• Variability of presynaptic nigrostriatal dopaminergic function and clinical heterogeneity in a dopa-responsive dystonia family with GCH-1 gene mutation

  2018influential citation
• Atypical presentation of dopa‐responsive dystonia in Taiwan

  2018cites this paper
• Dystonia as an unusual presentation of systemic mastocytosis: Possible link between histamine release and movement disorders.

  2018cites this paper
• MOLECULAR BASIS OF PATHOGENESIS OF DYSTONIA AMONG INDIAN PATIENTS

  2018influential citation
• Brain Kynurenine and BH4 Pathways: Relevance to the Pathophysiology and Treatment of Inflammation-Driven Depressive Symptoms

  2018cites this paper
• Management of Psychosis in a Patient with Probable Dopa-Responsive Dystonia

  2018cites this paper
• GCH1 mutations in dopa-responsive dystonia and Parkinson’s disease

  2018cites this paper
• Neuropsychological Difficulties Associated with Dopa Responsive Dystonia

  2018cites this paper
• Movement disorders Paroxysmal movement disorders : An update

  2018cites this paper
• Motor fluctuations and levodopa-induced dyskinesias in dopa-responsive dystonia.

  2018cites this paper
• Inherited dystonias: clinical features and molecular pathways.

  2018cites this paper
• Pregnancy management and outcome in patients with four different tetrahydrobiopterin disorders

  2018cites this paper
• Mutation in the GCH1 gene with dopa-responsive dystonia and phenotypic variability

  2018cites this paper
• Non-motor symptoms and quality of life in dopa-responsive dystonia patients.

  2017cites this paper
• Dopa- Responsive Dystonia

  2017cites this paper
• Available treatment options for dystonia

  2017cites this paper
• Beyond the Classic Segawa Disease, GCH1-Associated Neurodegenerative Parkinsonism: Practical Considerations for Physicians

  2017cites this paper
• l-Dopa in dystonia

  2017cites this paper
• Sleep fragmentation and Parkinson's disease pathology in older adults without Parkinson's disease

  2017cites this paper
• GCH1 mutations are common in Serbian patients with dystonia-parkinsonism: Challenging previously reported prevalence rates of DOPA-responsive dystonia.

  2017cites this paper
• Invited Review Dystonia

  2017cites this paper
• A novel tyrosine hydroxylase variant in a group of Chinese patients with dopa-responsive dystonia

  2017cites this paper
• Transcranial sonography in dopa‐responsive dystonia

  2017cites this paper
• Parkinsonism without dopamine neuron degeneration in aged l‐dopa‐responsive dystonia knockin mice

  2017cites this paper
• Clinical exome sequencing in early‐onset generalized dystonia and large‐scale resequencing follow‐up

  2017cites this paper
• Restless legs syndrome in Wilson's disease: frequency, characteristics, and mimics

  2017cites this paper
• A review of psychiatric co‐morbidity described in genetic and immune mediated movement disorders

  2017cites this paper
• Inherited Metabolic Disorders with Associated Movement Abnormalities

  2016cites this paper
• Dissecting the Genetic Basis of Parkinson Disease, Dystonia and Chorea

  2016cites this paper
• Paroxysmal movement disorders: An update.

  2016cites this paper
• Tremor in dystonia.

  2016cites this paper
• Adult‐Onset Alcohol Suppressible Cervical Dystonia: A Case Report

  2015cites this paper
• Dopa-responsive dystonia—clinical and genetic heterogeneity

  2015cites this paper
• Diagnosing dopamine-responsive dystonias

  2015cites this paper
• Childhood Dystonias

  2015cites this paper
• Monoamine neurotransmitter disorders—clinical advances and future perspectives

  2015cites this paper
• Two cases of early dystonia of the trunk in Parkinson’s disease

  2015cites this paper
• Nonmotor Symptoms in Dopa‐Responsive Dystonia

  2015influential citation
• GTP Cyclohydrolase 1-Deficient Dopa-Responsive Dystonia

  2015cites this paper
• Genetic and neuropathological study of primary and secondary dystonic syndromes

  2015cites this paper